Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis
…,DW Denning, E Johnson, VMehra… - European …, 2020 - Eur Respiratory Soc
… Denning, Elizabeth Johnson,Varun
Mehra, Tony Pagliuca, Brijesh Patel, Johanna
Rhodes, Silke Schelenz, Anand Shah, Frank L. van de Veerdonk, Paul E. Verweij, P …
Rhodes, Silke Schelenz, Anand Shah, Frank L. van de Veerdonk, Paul E. Verweij, P …
[PDF][PDF]Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience
…, M Zuckerman,J Vidler, S Sharif, VMehra… - Br J …, 2020 - researchgate.net
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged at the end of
2019 and caused an infection named COVID-19 (Guan, Ni et al. 2020). Patients with …
2019 and caused an infection named COVID-19 (Guan, Ni et al. 2020). Patients with …
[HTML][HTML]Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
…, P George, C Grimley, F Jack, L Munro, VMehra… - Leukemia, 2019 - nature.com
Determining the underlying cause of persistent eosinophilia is important for effective clinical
management but remains a diagnostic challenge in many cases. We identified STAT5B …
management but remains a diagnostic challenge in many cases. We identified STAT5B …
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients
…,T Lechmere, H Khan, MH Malim, C Harrison, VMehra… - Cancer Cell, 2021 - cell.com
SARS-CoV-2 has led to unprecedented global healthcare challenges, with poor outcomes
observed in groups with immune deficiency, including allogeneic stem cell transplantation (…
observed in groups with immune deficiency, including allogeneic stem cell transplantation (…
Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival
…, A Bloor,A Pagliuca, V Potter, VMehra… - British journal of …, 2019 - Wiley Online Library
Mesenchymal stromal cells ( MSC s) have been successfully used for the treatment of
steroid‐resistant graft‐versus‐host‐disease (Gv HD ). However, the lack of early predictors of …
steroid‐resistant graft‐versus‐host‐disease (Gv HD ). However, the lack of early predictors of …
Estimating the value of demand-side management in low-cost, solar micro-grids
VMehra, R Amatya,RJ Ram- Energy, 2018 - Elsevier
需求管理ential to reduce the cost of solar based community
micro-grids and solar home systems for electricity access. This paper presents a methodology …
micro-grids and solar home systems for electricity access. This paper presents a methodology …
Early and late‐onset veno‐occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation–a real‐world UK experience
VMehra, S Tetlow, A Choy… - American Journal of …, 2021 - Wiley Online Library
Classical veno‐occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a serious
complication post allogeneic hematopoietic stem cell transplantation (HSCT). Before the …
complication post allogeneic hematopoietic stem cell transplantation (HSCT). Before the …
Autologous hematopoietic stem cell transplantation in active multiple sclerosis: a real-world case series
…,O Ciccarelli,MP Sormani, E Olavarria, VMehra… - Neurology, 2021 - AAN Enterprises
Objective To examine outcomes in people with multiple sclerosis (PwMS) treated with autologous
hematopoietic stem cell transplantation (AHSCT) in a real-world setting. Methods This …
hematopoietic stem cell transplantation (AHSCT) in a real-world setting. Methods This …
[HTML][HTML]Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 …
…, C Cordonnier,S Meylan, VMehra… - Leukemia, 2022 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS-…
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS-…
Epstein-Barr virus and monoclonal gammopathy of clinical significance in autologous stem cell transplantation for multiple sclerosis
VMehra, E Rhone, S Widya… - Clinical Infectious …, 2019 - academic.oup.com
Introduction Autologous hematopoietic stem cell transplantation (AHSCT) with anti-thymocyte
globulin (ATG) conditioning as treatment of active multiple sclerosis (MS) is rapidly …
globulin (ATG) conditioning as treatment of active multiple sclerosis (MS) is rapidly …